膈肌功能参数、低蛋白血症和诱骗受体3、D-二聚体与老年慢性阻塞性肺疾病合并呼吸衰竭程度及治疗结局的关系

Correlations of diaphragm function indicators, hypoproteinemia, decoder receptor 3 and D-dimer with disease condition and treatment outcome of elderly patients with chronic obstructive pulmonary disease complicated with respiratory failure

  • 摘要:
    目的 探讨膈肌功能参数、低蛋白血症和诱骗受体3(DcR3)、D-二聚体(D-D)与老年慢性阻塞性肺疾病(COPD)合并呼吸衰竭患者病情程度及治疗结局的关系。
    方法 选取118例老年COPD合并呼吸衰竭患者为研究对象。根据动脉血氧分压pa(O2)将患者分为轻度组(n=27)、中度组(n=51)和重度组(n=40)。比较3组膈肌功能参数、DcR3、D-D及低蛋白血症情况。根据治疗28 d后的结局情况将患者分为治疗成功组(n=87)和治疗失败组(n=31)。采用单因素及多因素分析法分析膈肌功能参数、低蛋白血症及DcR3、D-D与不良结局的关系。
    结果 重度组患者的膈肌移动度、膈肌运动面积低于或小于中度组和轻度组, 差异有统计学意义(P<0.05); 中度组的膈肌移动度、膈肌运动面积低于或小于轻度组,差异有统计学意义(P<0.05)。重度组DcR3、D-D及低蛋白血症患者占比高于中度组和轻度组,中度组的DcR3、D-D高于轻度组,差异有统计学意义(P<0.05)。治疗失败组的年龄、急性生理功能和慢性健康状况评分系统Ⅱ(APACHE Ⅱ)评分、氨基末端脑钠肽前体(NT-proBNP)、合并冠心病患者占比高于治疗成功组,差异有统计学意义(P<0.05)。治疗失败组的膈肌移动度低于治疗成功组,膈肌运动面积小于治疗成功组,差异有统计学意义(P<0.05)。治疗失败组的DcR3、D-D及低蛋白血症患者占比高于治疗成功组,差异有统计学意义(P<0.001)。年龄大、APACHE Ⅱ评分高、NT-proBNP高、合并冠心病、DcR3高、D-D高、低蛋白血症、膈肌移动度降低、膈肌运动面积减小是老年COPD合并呼吸衰竭患者治疗不良结局的独立危险因素(P<0.05)。
    结论 老年COPD合并呼吸衰竭患者的膈肌移动度降低、膈肌运动面积减小和DcR3、D-D增高以及合并低蛋白血症均与其病情程度较重有关。

     

    Abstract:
    Objective To investigate the correlations of diaphragm function parameters, hypoalbuminemia, decoy receptor 3 (DcR3) and D-dimer (D-D) with disease severity and treatment outcomes of elderly patients with chronic obstructive pulmonary disease (COPD) complicated by respiratory failure.
    Methods A total of 118 elderly COPD patients with respiratory failure were selected as study subjects. Patients were divided into mild (n=27), moderate (n=51) and severe (n=40) groups based on arterial oxygen partial pressurepa(O2). Diaphragm function parameters, DcR3, D-D and hypoalbuminemia were compared among the three groups. Based on the treatment outcomes at 28 days, patients were further divided into treatment success group (n=87) and treatment failure group (n=31). Univariate and multivariate analyses were performed to assess the correlations of diaphragm function parameters, hypoalbuminemia, DcR3, and D-D with adverse outcomes.
    Results The diaphragm mobility and diaphragm movement area of patients in the severe group were significantly lower or smaller than those in the moderate group and the mild group(P < 0.05); the diaphragm mobility and diaphragm movement area of patients in the moderate group were significantly lower or smaller than those in the mild group (P < 0.05). The proportions of patients with DcR3, D-D and hypoproteinemia in the severe group were significantly higher than those in the moderate and mild groups, and the DcR3 and D-D in the moderate group were significantly higher than those in the mild group (P < 0.05). The age, Acute Physiological Function and Chronic Health Evaluation Ⅱ (APACHE Ⅱ) score, N-terminal pro-brain natriuretic peptide (NT-proBNP) and the proportion of patients with coronary heart disease in the treatment failure group were significantly higher than those in the treatment success group (P < 0.05). The diaphragm mobility in the treatment failure group was significantly lower than that in the treatment success group, and the diaphragm movement area was smaller than that in the treatment success group (P < 0.05). The proportions of patients with DcR3, D-D and hypoproteinemia in the treatment failure group were significantly higher than those in the treatment success group (P < 0.001). Older age, higher APACHE Ⅱ score, higher NT-proBNP, combined with coronary heart disease, higher DcR3, higher D-D level, hypoproteinemia, decreased diaphragm mobility and reduced diaphragm motor area were independent risk factors for adverse treatment outcomes in elderly patients with COPD complicated with respiratory failure (P < 0.05).
    Conclusion In elderly COPD patients with respiratory failure, reduced diaphragm mobility, decreased diaphragm motion area, elevated DcR3 and D-D levels and the presence of hypoalbuminemia are associated with more severe disease conditions.

     

/

返回文章
返回